The risk or severity of adverse effects can be increased when Diclofenac is combined with Mesalazine. The metabolism of Diclofenac can be decreased when combined with Idelalisib. The risk or severity of adverse effects can be increased when Diclofenac is combined with Metamizole. The risk or severity of adverse effects can be increased when Benazepril is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Parecoxib. The serum concentration of Diclofenac can be increased when it is combined with Capecitabine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clonixin. The risk or severity of adverse effects can be increased when Candesartan is combined with Diclofenac. The serum concentration of Diclofenac can be increased when it is combined with Probenecid. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tolmetin. The therapeutic efficacy of Limaprost can be decreased when used in combination with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Alclometasone. The risk or severity of adverse effects can be increased when Diclofenac is combined with Equilenin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Etoricoxib. The risk or severity of adverse effects can be increased when Diclofenac is combined with Lisofylline. Diclofenac may decrease the antihypertensive activities of Celiprolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Mizoribine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tolfenamic Acid. Diclofenac may decrease the antihypertensive activities of Bevantolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tenofovir disoproxil. Colestipol can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Diclofenac is combined with Etidronic acid. The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid. The serum concentration of Diclofenac can be decreased when it is combined with St. John's Wort. The risk or severity of adverse effects can be increased when Diclofenac is combined with Salsalate. The metabolism of Diclofenac can be decreased when combined with Atomoxetine. Diclofenac may increase the anticoagulant activities of Certoparin. Diclofenac may increase the neuroexcitatory activities of Norfloxacin. The serum concentration of Diclofenac can be decreased when it is combined with Phenobarbital. The metabolism of Diclofenac can be decreased when combined with Chloramphenicol. The metabolism of Diclofenac can be decreased when combined with Desipramine. The metabolism of Diclofenac can be decreased when combined with Moclobemide. The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Diclofenac. The serum concentration of Diclofenac can be increased when it is combined with Sulfadiazine. The metabolism of Diclofenac can be decreased when combined with Sulfamethoxazole. The metabolism of Diclofenac can be decreased when combined with Mexiletine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Ferulic acid. The risk or severity of adverse effects can be increased when Diclofenac is combined with Diflunisal. Diclofenac may decrease the antihypertensive activities of Nadolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Naftifine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Pimecrolimus. Diclofenac may decrease the antihypertensive activities of Talinolol. Diclofenac may increase the anticoagulant activities of Becaplermin. The risk or severity of adverse effects can be increased when Fimasartan is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Curcumin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tiludronic acid. The therapeutic efficacy of Beraprost can be decreased when used in combination with Diclofenac. Diclofenac may increase the neuroexcitatory activities of Grepafloxacin. The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Isradipine. The serum concentration of Diclofenac can be increased when it is combined with Dosulepin. The metabolism of Diclofenac can be decreased when combined with Pioglitazone. The serum concentration of Diclofenac can be decreased when it is combined with Carbamazepine. The metabolism of Diclofenac can be decreased when combined with Eslicarbazepine acetate. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clobetasone. The therapeutic efficacy of Dinoprost can be decreased when used in combination with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Betamethasone. The risk or severity of adverse effects can be increased when Omapatrilat is combined with Diclofenac. Diclofenac may increase the anticoagulant activities of Ardeparin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Desmopressin. Diclofenac may increase the anticoagulant activities of Argatroban. The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocinonide. Diclofenac may decrease the antihypertensive activities of Landiolol. The metabolism of Diclofenac can be decreased when combined with Cimetidine. Diclofenac may decrease the excretion rate of Neomycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Salicylic acid. The metabolism of Diclofenac can be decreased when combined with Pyrimethamine. Diclofenac may increase the anticoagulant activities of Citric Acid. Diclofenac may increase the anticoagulant activities of Edetic Acid. Diclofenac may increase the anticoagulant activities of Abciximab. The risk or severity of adverse effects can be increased when Diclofenac is combined with Desoxycorticosterone Pivalate. Diclofenac may increase the anticoagulant activities of Apixaban. Diclofenac may decrease the excretion rate of Geneticin which could result in a higher serum level. Diclofenac may increase the anticoagulant activities of Fondaparinux. The serum concentration of Colchicine can be increased when it is combined with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Halcinonide. Diclofenac may decrease the excretion rate of Tobramycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Diclofenac is combined with Zaltoprofen. Diclofenac may increase the anticoagulant activities of Warfarin. Sodium phosphate may increase the nephrotoxic activities of Diclofenac. Diclofenac may increase the anticoagulant activities of Ethyl biscoumacetate. The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluticasone furoate. Diclofenac may increase the anticoagulant activities of Letaxaban. The risk or severity of adverse effects can be increased when Diclofenac is combined with Choline magnesium trisalicylate. The risk or severity of adverse effects can be increased when Diclofenac is combined with Formestane. The risk or severity of adverse effects can be increased when Diclofenac is combined with Difluprednate. Diclofenac may decrease the antihypertensive activities of Triamterene. The serum concentration of Diclofenac can be decreased when it is combined with Cyproterone acetate. Diclofenac may increase the neuroexcitatory activities of Prulifloxacin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Lumiracoxib. The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Diclofenac. The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Diclofenac. The risk or severity of adverse effects can be increased when Diclofenac is combined with Medrysone. The risk or severity of adverse effects can be increased when Diclofenac is combined with Nabumetone. Diclofenac may increase the anticoagulant activities of Gabexate. The serum concentration of Diclofenac can be increased when it is combined with Lumacaftor. Diclofenac may decrease the antihypertensive activities of Carteolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Sertraline. The metabolism of Diclofenac can be decreased when combined with Cholecalciferol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clocortolone. The metabolism of Diclofenac can be decreased when combined with Clopidogrel. Diclofenac may increase the anticoagulant activities of Darexaban. Diclofenac may decrease the antihypertensive activities of Timolol. The risk or severity of adverse effects can be increased when Diclofenac is combined with Cortisone acetate. The risk or severity of adverse effects can be increased when Diclofenac is combined with Clodronic Acid. The metabolism of Diclofenac can be decreased when combined with Lobeglitazone. The serum concentration of Diclofenac can be decreased when it is combined with Enzalutamide. The metabolism of Diclofenac can be decreased when combined with Zucapsaicin. The risk or severity of adverse effects can be increased when Diclofenac is combined with Naproxen. Diclofenac may increase the neuroexcitatory activities of Rosoxacin. Diclofenac may increase the anticoagulant activities of Dalteparin. The metabolism of Diclofenac can be decreased when combined with Felodipine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Niflumic Acid. The risk or severity of adverse effects can be increased when Diclofenac is combined with Zoledronic acid. The metabolism of Diclofenac can be decreased when combined with Ropinirole. The metabolism of Diclofenac can be decreased when combined with Itraconazole. The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Diclofenac. Diclofenac may decrease the antihypertensive activities of Platelet Activating Factor. The risk or severity of adverse effects can be increased when Diclofenac is combined with Evening primrose oil. The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac. The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Diclofenac. The serum concentration of Diclofenac can be increased when it is combined with Mifepristone. The serum concentration of Ranolazine can be increased when it is combined with Diclofenac. The metabolism of Diclofenac can be decreased when combined with Quinine. The risk or severity of adverse effects can be increased when Diclofenac is combined with Tranilast. The risk or severity of adverse effects can be increased when Talniflumate is combined with Diclofenac. Diclofenac may increase the anticoagulant activities of Pentaerythritol Tetranitrate. The risk or severity of adverse effects can be increased when Diclofenac is combined with Pamidronate.